HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hailin Zhang Selected Research

procyanidin B1

1/2020Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hailin Zhang Research Topics

Disease

40Neoplasms (Cancer)
08/2022 - 12/2011
16Infections
01/2022 - 03/2010
15Inflammation (Inflammations)
01/2022 - 12/2007
12Pain (Aches)
01/2021 - 04/2010
10Breast Neoplasms (Breast Cancer)
01/2021 - 09/2013
6Body Weight (Weight, Body)
01/2022 - 09/2015
6Acute Lung Injury
01/2022 - 02/2015
6Hepatocellular Carcinoma (Hepatoma)
12/2021 - 01/2018
5Carcinogenesis
01/2022 - 12/2018
5Asthma (Bronchial Asthma)
01/2022 - 01/2017
4Chronic Pain
01/2022 - 01/2017
4Adenocarcinoma of Lung
01/2022 - 01/2019
4Pneumonia (Pneumonitis)
01/2021 - 11/2014
4Hypertension (High Blood Pressure)
01/2021 - 02/2016
4Neuralgia (Stump Neuralgia)
01/2021 - 12/2017
4Melanoma (Melanoma, Malignant)
07/2019 - 01/2017
4Shock
04/2016 - 10/2014
3Neoplasm Metastasis (Metastasis)
03/2022 - 12/2011
3Pulmonary Edema
01/2022 - 02/2015
3Lung Injury
12/2021 - 08/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2021 - 02/2015
3Wounds and Injuries (Trauma)
12/2021 - 08/2015
3Atherosclerosis
11/2021 - 01/2012
3Fibrosis (Cirrhosis)
11/2021 - 05/2015
3Seizures (Absence Seizure)
01/2019 - 01/2015
3Triple Negative Breast Neoplasms
01/2018 - 09/2013
3Stomach Ulcer (Gastric Ulcer)
12/2017 - 06/2015
3Lung Neoplasms (Lung Cancer)
01/2017 - 12/2011
3Septic Shock (Toxic Shock Syndrome)
11/2016 - 01/2016
3Encephalitis (Encephalitis, Rasmussen)
06/2013 - 11/2010
2Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2022
2Extensively Drug-Resistant Tuberculosis
05/2022 - 01/2022
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
05/2022 - 01/2021
2Hyperalgesia
01/2022 - 01/2019
2Liver Neoplasms (Liver Cancer)
01/2022 - 01/2020
2Necrosis
01/2022 - 10/2016
2Carcinoma (Carcinomatosis)
01/2022 - 10/2016
2Vascular Diseases (Vascular Disease)
12/2021 - 11/2016
2Type 2 Diabetes Mellitus (MODY)
11/2021 - 01/2017
2Virus Diseases (Viral Diseases)
09/2021 - 01/2020
2Ascites
03/2021 - 02/2021
2Keloid
03/2021 - 10/2020
2Squamous Cell Carcinoma of Head and Neck
01/2021 - 01/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2021
2Rabies (Hydrophobia)
11/2020 - 12/2019
2Hypoxia (Hypoxemia)
10/2020 - 01/2018
2Epilepsy (Aura)
01/2020 - 11/2015

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
08/2022 - 08/2003
17Pharmaceutical PreparationsIBA
04/2022 - 04/2010
8LipopolysaccharidesIBA
08/2017 - 02/2015
7Ion Channels (Ion Channel)IBA
01/2022 - 12/2007
7Transcription Factors (Transcription Factor)IBA
11/2019 - 09/2013
6Interleukin-6 (Interleukin 6)IBA
08/2017 - 02/2015
5Oxygen (Dioxygen)IBA
04/2022 - 11/2014
5CytokinesIBA
01/2022 - 09/2015
5cavidineIBA
08/2017 - 04/2015
4MicroRNAs (MicroRNA)IBA
12/2021 - 01/2017
4Factor V (Coagulation Factor V)IBA
11/2019 - 09/2013
4Voltage-Gated Sodium ChannelsIBA
01/2019 - 10/2007
4Ethanol (Ethyl Alcohol)IBA
12/2017 - 06/2015
4BradykininIBA
10/2015 - 04/2010
3Serum AlbuminIBA
10/2022 - 01/2022
3Biological ProductsIBA
05/2022 - 07/2019
3Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2019
3AntioxidantsIBA
01/2022 - 09/2015
3Anti-Bacterial Agents (Antibiotics)IBA
09/2021 - 08/2019
3fibroblast growth factor 13IBA
01/2021 - 01/2017
3gamma-Aminobutyric Acid (GABA)IBA
01/2021 - 09/2015
3Cisplatin (Platino)FDA LinkGeneric
01/2021 - 02/2015
3ezogabine (retigabine)IBA
01/2020 - 01/2015
3Potassium Channels (Potassium Channel)IBA
01/2020 - 08/2003
3Chloride Channels (Chloride Channel)IBA
01/2020 - 01/2019
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2019 - 04/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2019 - 02/2015
3Esculin (Aesculin)IBA
04/2017 - 12/2015
3Biomarkers (Surrogate Marker)IBA
01/2017 - 09/2013
3Dinoprostone (PGE2)FDA Link
04/2015 - 10/2014
2RNA (Ribonucleic Acid)IBA
08/2022 - 11/2010
2CalciumIBA
08/2022 - 01/2020
2Linezolid (Zyvox)FDA Link
05/2022 - 01/2022
2Phosphotransferases (Kinase)IBA
03/2022 - 12/2019
2Amino AcidsFDA Link
03/2022 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2022 - 02/2021
2Immunoglobulin M (IgM)IBA
01/2022 - 05/2011
2apelin-13 peptideIBA
12/2021 - 01/2018
2CollagenIBA
11/2021 - 10/2020
2VaccinesIBA
09/2021 - 08/2019
2Long Noncoding RNAIBA
01/2021 - 01/2017
2Lysine (L-Lysine)FDA Link
01/2021 - 05/2018
2Sodium Channels (Sodium Channel)IBA
01/2021 - 01/2019
2Epidermal Growth Factor (EGF)IBA
01/2021 - 12/2011
2florfenicolIBA
01/2021 - 01/2021
2Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
01/2020 - 10/2016
2IronIBA
01/2020 - 11/2015

Therapy/Procedure

19Therapeutics
04/2022 - 07/2015
7Immunotherapy
01/2022 - 01/2018
3Drug Therapy (Chemotherapy)
12/2020 - 10/2015
2Renal Dialysis (Hemodialysis)
10/2022 - 08/2022
2Surgical Flaps
03/2021 - 08/2015
2Oncolytic Virotherapy
02/2021 - 01/2020